LAMICTAL 200 mg COMPRIMIDOS MASTICABLES/DISPERSABLES

Laboratoire Glaxosmithkline🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: d2fd8b3bde29f4b5
Drug Cima Aemps Name: LAMICTAL 200 mg COMPRIMIDOS MASTICABLES/DISPERSABLES
Register Number: 3400934147364
Holder Company Name: Laboratoire Glaxosmithkline
Marketing Company Name: Difarmed S.L.U.
Holder Company Detail Path: /organization/laboratoire-glaxosmithkline
Authorization Date: 2024-06-24
Dosage Form: COMPRIMIDO MASTICABLE Y DISPERSABLE
Dose: Lamotrigina 200 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica. Tratamiento De Larga Duración
Commercialized: Yes
Company Name: Laboratoire Glaxosmithkline
Company Detail Path: /organization/laboratoire-glaxosmithkline

LAMOTRIGINA

200 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jun 24, 2024

Approval ID

d2fd8b3bde29f4b5

Type

Standard